Featured
A new draft recommendation
relating to anticoagulation for discharged patients with COVID-19 has
been issued by the American Society of Hematology (ASH).For patients with COVID-19 who
are being discharged from the hospital and who do not have suspected or
confirmed venous thromboembolism or another indication for anticoagulation, the
ASH guide...
A study published Oct. 12
in the Annals of Internal Medicine that compared three types of direct oral
anticoagulants (DOACs) found that rivaroxaban was associated with a much higher
risk of overall and major gastrointestinal bleeding than apixaban or
dabigatran, according to a study. Other studies yield similar results.The researchers found
th...
This WHO Therapeutics and COVID-19: living guideline now includes two recommendations regarding the combination of neutralizing monoclonal antibodies, Casirivimab and Imdevimab: a conditional recommendation in favour of use in non-severe patients (the condition being patients’ risk of severe disease: patients at highest risk represent good candidat...
Key facts
Antibiotic
resistance is one of the biggest threats to global health, food security,
and development today.
Antibiotic
resistance can affect anyone, of any age, in any country.
Antibiotic
resistance occurs naturally, but misuse of antibiotics in humans and
animals is accelerating the process.
A gr...
Revised guideline for clinical
management of Dengue4th Edition 2018, Revised
(Printed May, 2020)
The draft version of revised
guideline for clinical management of Dengue. The revised guideline contains new
conception regarding pediatric management as well as management of Dengue in
pregnancy. Dengue in Covid19 context has been briefly d...
Novel Coronavirus (COVID-19)
Guidelines of Bangladesh.
The guidelines for the diagnosis,
treatment, and control of the coronavirus disease (COVID-19).
Antibiotic resistance is one of the greatest public health challenges of
our time—few treatment options exist for people infected with
antibiotic-resistant bacteria.
Ivermectin is an antiparasitic
drug that is approved by the Food and Drug Administration (FDA) for the
treatment of onchocerciasis and strongyloidiasis. Ivermectin is not
FDA-approved for the treatment of any viral infection. In general, the drug is
well tolerated. It is currently being evaluated as a potential treatment for
COVID-19.
Iverm...
The COVID-19 Treatment Guidelines have been developed to
inform clinicians how to care for patients with COVID-19. Because clinical
information about the optimal management of COVID-19 is evolving quickly.
The recommendations in these Guidelines are based on scientific
evidence and expert opinion. Each recommendation includes two...
This guidance document is
intended for clinicians caring for COVID-19 patients during all phases of their
disease (i.e., screening to discharge). This update has been expanded to
meet the needs of front-line clinicians and promotes a multi-disciplinary
approach to care for patients with COVID-19, including those with mild,
moderate, severe, a...
National guidelines version 8th on clinical management of Coronavirus
disease by Disease Control Division, Directorate General of Health
Services, Ministry of Health & Family Welfare & Government of the
People's Republic of Bangladesh.
The guideline includes clinical management of COVID-19 and
is updated with the latest evide...
An Aid to the Management of
COVID-19 in Bangladesh: “Lessons from the western experience” New 5th Edition
This book is a small effort by
some highly-motivated Bangladeshi doctors living in the UK and the USA to
supplement local guidelines in Bangladesh. This will hopefully enable local
experts in Bangladesh to be kept updated...
